Investigational Medicinial Product (IMP) & Placebo Manufacture - IM Woman Trial (Ангилья - Тендер #45280086) | ||
| ||
| Для перевода текста тендера на нужный язык воспользуйтесь приложением: | ||
Страна: Ангилья (другие тендеры и закупки Ангилья) Организатор тендера: Sell2Wales – Government´s Initiative Номер конкурса: 45280086 Дата публикации: 22-08-2023 Источник тендера: Sell2Wales – Government´s Initiative |
||
Results of the procurement procedure
Section I: Contracting entity I.1) Name and addressesLondon School of Hygiene & Tropical Medicine
RC000330
Keppel Street,
London
WC1E 7HT
UK
Contact person: Paul Pester
Telephone: +44 02079272471
E-mail: paul.pester@lshtm.ac.uk
NUTS: UKI31
Internet address(es)
Main address: http://www.lshtm.ac.uk
Address of the buyer profile: https://uk.eu-supply.com/ctm/Company/CompanyInformation/Index/104519
I.4) Type of the contracting authorityBody governed by public law
I.5) Main activityHealth
Section II: Object II.1) Scope of the procurement II.1.1) TitleInvestigational Medicinial Product (IMP) & Placebo Manufacture - IM Woman Trial
Reference number: LSHTM-2021-29
II.1.2) Main CPV code33600000
II.1.3) Type of contractSupplies
II.1.4) Short descriptionManufacturing and packing of IMP for the IM Woman Trial due to commence in March 2023.
Three arms include experimental treatment (IM TXA), reference treatment/active control (IV TXA), and placebo control (0.9% sodium chloride solution).
Treatment Kit Boxes required for 4 campaigns with approximately 10,000 patient packs per campaign. Recruitment period is 24 months - campaign approximately once every 6 months.
II.1.6) Information about lotsThis contract is divided into lots: No
II.1.7) Total value of the procurementValue excluding VAT: 1 066 444.00 GBP
II.2) Description II.2.2) Additional CPV code(s)33141310
33141320
33621000
33621200
33698000
39299100
44617100
79920000
II.2.3) Place of performanceNUTS code:
UKI31
Main site or place of performance:
LSHTM - Keppel Street, London WC1A 7HT
II.2.4) Description of the procurementManufacturing and packing of IMP for the IM Woman Trial due to commence in March 2023.
A randomised, triple-blind, three-arm, non-inferiority trial to assess the efficacy and safety of intramuscular tranexamic acid compared to intravenous tranexamic acid and placebo in women having vvaginal and caesarean section births.
Three arms include experimental treatment (IM TXA), reference treatment/active control (IV TXA), and placebo control (0.9% sodium chloride solution).
Treatment Kit Boxes required for 4 campaigns with approximately 10,000 patient packs per campaign. Recruitment period is 24 months - campaign approximately once every 6 months.
II.2.5) Award criteriaQuality criterion: Technical / Weighting: 70
Price / Weighting: 30
II.2.11) Information about optionsOptions: No
II.2.13) Information about European Union fundsThe procurement is related to a project and/or programme financed by European Union funds: No
Section IV: Procedure IV.1) Description IV.1.1) Type of procedureOpen procedure
IV.1.8) Information about Government Procurement Agreement (GPA)The procurement is covered by the Government Procurement Agreement: Yes
IV.2) Administrative information IV.2.1) Previous publication concerning this procedureNotice number in the OJ S:
2021/S 000-029090
Section V: Award of contractContract No: 1
Title: Investigational Medicinial Product (IMP) & Placebo Manufacture - IM Woman Trial
A contract/lot is awarded: Yes
V.2 Award of contract V.2.1) Date of conclusion of the contract10/08/2023
V.2.2) Information about tendersNumber of tenders received: 1
Number of tenders received by electronic means: 1
The contract has been awarded to a group of economic operators: No
V.2.3) Name and address of the contractorSharp Clinical Services (UK) Ltd
2234557
Unit 28, Heol Klockner
Rhymney
NP22 5RL
UK
E-mail: Rachel.curran@sharpclinical.com
NUTS: UK
The contractor is an SME: No
V.2.4) Information on value of the contract/lot (excluding VAT)Total value of the contract/lot: : 1 066 444.00 GBP
V.2.5) Information about subcontracting Section VI: Complementary information VI.4) Procedures for review VI.4.1) Review bodyThe Royal Courts of Justice
The Strand
London
WC2A 2LL
UK
VI.4.4) Service from which information about the review procedure may be obtainedLondon School of Hygiene & Tropical Medicine
Keppel Street
London
WC1E 7HT
UK
E-mail: procurement@lshtm.ac.uk
VI.5) Date of dispatch of this notice21/08/2023
Information added to the notice since publication.
Additional information added to the notice since it"s publication.| No further information has been uploaded. |
| Main Contact: | paul.pester@lshtm.ac.uk |
| Admin Contact: | N/a |
| Technical Contact: | N/a |
| Other Contact: | N/a |
| ID | Title | Parent Category |
|---|---|---|
| 33621200 | Antihaemorrhagics | Medicinal products for the blood and blood-forming organs |
| 44617100 | Cartons | Boxes |
| 33698000 | Clinical products | Various medicinal products |
| 39299100 | Glass ampoules | Glassware |
| 33141320 | Medical needles | Disposable non-chemical medical consumables and haematological consumables |
| 33621000 | Medicinal products for the blood and blood-forming organs | Medicinal products for the blood, blood-forming organs and the cardiovascular system |
| 79920000 | Packaging and related services | Miscellaneous business and business-related services |
| 33600000 | Pharmaceutical products | Medical equipments, pharmaceuticals and personal care products |
| 33141310 | Syringes | Disposable non-chemical medical consumables and haematological consumables |
| ID | Description |
|---|---|
| 100 | UK - All |
The buyer has restricted the alert for this notice to suppliers based in the following regions.
Alert Region Restrictions| There are no alert restrictions for this notice. |